{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:41:17Z","timestamp":1791686477428,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FP7 project DETECTIVE","award":["266838"],"award-info":[{"award-number":["266838"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.tox.2017.11.013","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T19:30:50Z","timestamp":1510687850000},"page":"160-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1421-8214","authenticated-orcid":false,"given":"Simone G.J.","family":"van Breda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.H.","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"van Herwijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00ebl H.J.","family":"Theunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyel G.J.","family":"Jennen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo M.C.M.","family":"de Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos C.S.","family":"Kleinjans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tox.2017.11.013_bib0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000439083","article-title":"2015) tissue inhibitors of metalloproteinase-1 and 2 and obesity related non-Alcoholic fatty liver disease: is there a relationship","volume":"92","author":"Abdelaziz","year":"2015","journal-title":"Digestion"},{"issue":"3","key":"10.1016\/j.tox.2017.11.013_bib0010","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1111\/aos.12035","article-title":"Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy","volume":"91","author":"Abu El-Asrar","year":"2013","journal-title":"Acta Ophthalmol. (Copenh.)"},{"issue":"2014","key":"10.1016\/j.tox.2017.11.013_bib0015","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.bbalip.2014.07.017","article-title":"Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver","volume":"1841","author":"Asimakopoulou","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.tox.2017.11.013_bib0020","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00204-014-1279-6","article-title":"From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects","volume":"88","author":"Balmer","year":"2014","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.tox.2017.11.013_bib0025","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1478-3231.2010.02248.x","article-title":"Apoptosis is associated with CD36\/fatty acid translocase upregulation in non-alcoholic steatohepatitis","volume":"30","author":"Bechmann","year":"2010","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.tox.2017.11.013_bib0030","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12072-008-9075-0","article-title":"Hepatocellular adenoma: what is new in 2008","volume":"2","author":"Bioulac-Sage","year":"2008","journal-title":"Hepatol. Int."},{"issue":"December (12)","key":"10.1016\/j.tox.2017.11.013_bib0035","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tox.2017.11.013_bib0040","first-page":"385","article-title":"On the propyl derivates and decomposition products of ethylacetoacetate","volume":"3","author":"Burton","year":"1882","journal-title":"Am. Chem. J."},{"issue":"12","key":"10.1016\/j.tox.2017.11.013_bib0045","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1517\/13543784.2013.853037","article-title":"New perspectives of valproic acid in clinical practice","volume":"22","author":"Cincarova","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.tox.2017.11.013_bib0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13029-015-0035-5","article-title":"MagiCMicroRna: a web implementation of AgiMicroRna using shiny","volume":"10","author":"Coonen","year":"2015","journal-title":"Source Code Biol. Med."},{"issue":"1","key":"10.1016\/j.tox.2017.11.013_bib0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2010.08.007","article-title":"Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease","volume":"54","author":"Derdak","year":"2011","journal-title":"J. Hepatol."},{"issue":"30","key":"10.1016\/j.tox.2017.11.013_bib0060","doi-asserted-by":"crossref","first-page":"27586","DOI":"10.1074\/jbc.M303740200","article-title":"Valproate induces replication-independent active DNA demethylation","volume":"278","author":"Detich","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.tox.2017.11.013_bib0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treatment Rev."},{"issue":"1","key":"10.1016\/j.tox.2017.11.013_bib0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tox.2017.11.013_bib0075","doi-asserted-by":"crossref","first-page":"W71","DOI":"10.1093\/nar\/gkt293","article-title":"User-friendly solutions for microarray quality control and pre-processing on ArrayAnalysis. org","volume":"41","author":"Eijssen","year":"2013","journal-title":"Nucleic Acids Res. (Web Server issue)"},{"issue":"3","key":"10.1016\/j.tox.2017.11.013_bib0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy?analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.tox.2017.11.013_bib0085","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.tox.2017.11.013_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep20544","article-title":"Omics for prediction of environmental health effects: blood leukocyte-based cross-omic profiling reliably predicts diseases associated with tobacco smoking","volume":"6","author":"Georgiadis","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.tox.2017.11.013_bib0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"issue":"4","key":"10.1016\/j.tox.2017.11.013_bib0100","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/MCB.21.4.1393-1403.2001","article-title":"Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis","volume":"21","author":"Hayhurst","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"44","key":"10.1016\/j.tox.2017.11.013_bib0105","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1073\/pnas.0806560105","article-title":"Persistent epigenetic differences associated with prenatal exposure to famine in humans","volume":"105","author":"Heijmans","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tox.2017.11.013_bib0110","doi-asserted-by":"crossref","first-page":"D163","DOI":"10.1093\/nar\/gkq1107","article-title":"miRTarBase: a database curates experimentally validated microRNA-target interactions","volume":"39","author":"Hsu","year":"2011","journal-title":"Nucleic Acids Res. (Database issue)"},{"issue":"4","key":"10.1016\/j.tox.2017.11.013_bib0115","first-page":"450","article-title":"Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions","volume":"5","author":"Hunsberger","year":"2013","journal-title":"Am. J. Trans. Res."},{"key":"10.1016\/j.tox.2017.11.013_bib0120","doi-asserted-by":"crossref","first-page":"D712","DOI":"10.1093\/nar\/gkq1156","article-title":"ConsensusPathDB: toward a more complete picture of cell biology","volume":"39","author":"Kamburov","year":"2011","journal-title":"Nucleic Acids Res.(Database issue)"},{"key":"10.1016\/j.tox.2017.11.013_bib0125","first-page":"176","article-title":"Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease","author":"Kotronen","year":"2010","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.tox.2017.11.013_bib0130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00204-012-0967-3","article-title":"Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach","volume":"87","author":"Krug","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.tox.2017.11.013_bib0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/1354750X.2015.1118542","article-title":"et al. Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review","volume":"21","author":"L\u0103daru","year":"2016","journal-title":"Biomarkers"},{"key":"10.1016\/j.tox.2017.11.013_bib0140","series-title":"Description of Prototype Modes-of-action Related to Repeated Dose Toxicity JRC Scientific and Policy Reports","author":"Landesmann","year":"2012"},{"issue":"1","key":"10.1016\/j.tox.2017.11.013_bib0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.taap.2006.12.016","article-title":"Gene expression profiles of murine fatty liver induced by the administration of valproic acid","volume":"220","author":"Lee","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2017.11.013_bib0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2164-12-64","article-title":"Pre-processing and differential expression analysis of Agilent microRNA arrays using the AgiMicroRna Bioconductor library","volume":"12","author":"Lopez-Romero","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tox.2017.11.013_bib0155","doi-asserted-by":"crossref","first-page":"592354","DOI":"10.1155\/2012\/592354","article-title":"Regulation of the hepatocyte cell cycle: signaling pathways and protein kinases","volume":"2012","author":"Loyer","year":"2012","journal-title":"Int. J. Hepatol."},{"key":"10.1016\/j.tox.2017.11.013_bib0160","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.celrep.2016.07.078","article-title":"A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction","volume":"16","author":"Mavilio","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.tox.2017.11.013_bib0165","doi-asserted-by":"crossref","first-page":"e1756","DOI":"10.1038\/cddis.2015.121","article-title":"Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells","volume":"6","author":"Meganathan","year":"2015","journal-title":"Cell. Death. Dis."},{"issue":"2014","key":"10.1016\/j.tox.2017.11.013_bib0170","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/jgh.12614","article-title":"The serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis","volume":"29","author":"Miller","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.tox.2017.11.013_bib0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/carcin\/bgl167","article-title":"Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes","volume":"28","author":"Milutinovic","year":"2007","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.tox.2017.11.013_bib0180","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s001250051261","article-title":"Hepatocyte nuclear factor-6: associations between genetic variability and type II diabetes and between genetic variability and estimates of insulin secretion","volume":"42","author":"Moller","year":"1999","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.tox.2017.11.013_bib0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4274\/Jcrpe.584","article-title":"Early onset of liver steatosis in a Japanese girl with maturity-onset diabetes of the young type 3 (MODY3)","volume":"4","author":"Nakamura","year":"2012","journal-title":"J. Clin. Res. Pediatric Endocrinol."},{"key":"10.1016\/j.tox.2017.11.013_bib0190","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","article-title":"Noxa, a BH3-Only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis","volume":"288","author":"Oda","year":"2000","journal-title":"Science"},{"issue":"42","key":"10.1016\/j.tox.2017.11.013_bib0195","doi-asserted-by":"crossref","first-page":"40736","DOI":"10.1074\/jbc.M307973200","article-title":"The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression","volume":"278","author":"Pawar","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.tox.2017.11.013_bib0200","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)81432-4","article-title":"Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha","volume":"93","author":"Peet","year":"1998","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.tox.2017.11.013_bib0205","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1093\/bioinformatics\/btq522","article-title":"Evidence mining and novelty assessment of protein\u2013protein interactions with the ConsensusPathDB plugin for Cytoscape","volume":"26","author":"Pentchev","year":"2010","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.tox.2017.11.013_bib0210","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.tox.2017.11.013_bib0215","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gut.25.6.673","article-title":"Hepatotoxicity to sodium valproate: a review","volume":"25","author":"Powell-Jackson","year":"1984","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.tox.2017.11.013_bib0220","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tox.2017.11.013_bib0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2016.05.002","article-title":"Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma","volume":"350-352","author":"Rieswijk","year":"2016","journal-title":"Toxicology"},{"issue":"7245","key":"10.1016\/j.tox.2017.11.013_bib0230","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature08144","article-title":"The structure and function of G-protein-coupled receptors","volume":"459","author":"Rosenbaum","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.tox.2017.11.013_bib0235","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/toxsci\/kfv094","article-title":"Gene expression regulation and pathway analysis after valproic acid and carbamazepine exposure in a human embryonic stem cell-Based neurodevelopmental toxicity assay","volume":"146","author":"Schulpen","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"11","key":"10.1016\/j.tox.2017.11.013_bib0240","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"issue":"4","key":"10.1016\/j.tox.2017.11.013_bib0245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/86871","article-title":"Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism","volume":"27","author":"Shih","year":"2001","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.tox.2017.11.013_bib0250","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.tox.2017.11.013_bib0255","series-title":"Bioinformatics and Computational Biology Solutions Using R and Bioconductor","first-page":"397","article-title":"Limma: linear models for microarray data","author":"Smyth","year":"2005"},{"issue":"2","key":"10.1016\/j.tox.2017.11.013_bib0260","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/toxsci\/kfi185","article-title":"Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes","volume":"86","author":"Tong","year":"2005","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2017.11.013_bib0265","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/1354750X.2012.738249","article-title":"Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases","volume":"18","author":"Toyoda","year":"2012","journal-title":"Biomarkers"},{"issue":"7","key":"10.1016\/j.tox.2017.11.013_bib0270","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1021\/acs.chemrestox.5b00208","article-title":"Adverse outcome pathways and drug-Induced liver injury testing","volume":"28","author":"Vinken","year":"2015","journal-title":"Chem. Res. Toxicol."},{"issue":"17","key":"10.1016\/j.tox.2017.11.013_bib0275","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1093\/nar\/gkr416","article-title":"ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity","volume":"39","author":"Young","year":"2011","journal-title":"Nucleic acids Res."},{"issue":"3","key":"10.1016\/j.tox.2017.11.013_bib0280","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1021\/tx400402j","article-title":"Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells","volume":"27","author":"Waldmann","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.tox.2017.11.013_bib0285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3727\/105221615X14181438356292","article-title":"Role of hepatocyte nuclear factor 4alpha (HNF4alpha) in cell proliferation and cancer","volume":"16","author":"Walesky","year":"2015","journal-title":"Gene Expr."},{"issue":"2","key":"10.1016\/j.tox.2017.11.013_bib0290","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jmcb\/mjs064","article-title":"A new role of p53 in regulating lipid metabolism","volume":"5","author":"Wang","year":"2013","journal-title":"J. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.tox.2017.11.013_bib0295","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jhep.2008.03.018","article-title":"Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats","volume":"49","author":"Wei","year":"2008","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.tox.2017.11.013_bib0300","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1021\/acs.chemrestox.6b00337","article-title":"Integrative \u2212Omics analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-Induced cholestasis","volume":"29","author":"Wolters","year":"2016","journal-title":"Chem. Res. Toxicol."},{"issue":"August","key":"10.1016\/j.tox.2017.11.013_bib0305","first-page":"2017","article-title":"Nuclear and mitochondrial DNA methylation patterns induced by valproic acid in human hepatocytes","volume":"30","author":"Wolters","year":"2017","journal-title":"Chem. Res. Toxicol. Publ. Date (Web)"},{"issue":"20","key":"10.1016\/j.tox.2017.11.013_bib0310","doi-asserted-by":"crossref","first-page":"20571","DOI":"10.1074\/jbc.M400884200","article-title":"p53 involvement in the pathogenesis of fatty liver disease","volume":"279","author":"Yahagi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2017.11.013_bib0315","article-title":"Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis","author":"van Breda","year":"2014","journal-title":"Arch. Toxicol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X17303438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X17303438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:38:15Z","timestamp":1759534695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X17303438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":63,"alternative-id":["S0300483X17303438"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2017.11.013","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2017.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}